Company: DHR
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0000313616-25-000043
Chunk: 46

Company: DANAHER CORP /DE/
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 46
---
 information related to the fair value of the Company sponsored defined benefit pension plan assets.

NOTE 12.  ACCRUED EXPENSES AND OTHER LIABILITIES 

Accrued expenses and other liabilities as of December 31 were as follows ($ in millions): 20242023 CurrentNoncurrentCurrentNoncurrentCompensation and benefits$1,101 $289 $1,127 $254 Pension and postretirement benefits56 560 57 544 Taxes, income and other568 3,138 582 3,428 Contract liabilities1,299 232 1,465 249 Sales and product allowances185 6 155 6 Operating lease liabilities173 968 180 954 Contract settlement financing payable75 287 75 354 Other1,083 214 1,172 228 Total$4,540 $5,694 $4,813 $6,017 

81

NOTE 13.  FINANCING 

The components of the Company’s debt as of December 31 were as follows (amounts in millions):Outstanding AmountDescription and Aggregate Principal Amount20242023Euro-denominated commercial paper (€931 million and €929 million, respectively)(e)$965 $1,026 1.7% senior unsecured notes due 3/30/2024 (€900 million) (the “2024 Euronotes”)(f)— 993 2.2% senior unsecured notes due 11/15/2024 ($700 million) (the “2024 Biopharma Notes”)(b)— 699 3.35% senior unsecured notes due 9/15/2025 ($500 million) (the “2025 U.S. Notes”)(f)500 499 0.2% senior unsecured notes due 3/18/2026 (€1.3 billion) (the “2026 Biopharma Euronotes”)(b)1,293 1,376 2.1% senior unsecured notes due 9/30/2026 (€800 million) (the “2026 Euronotes”)(f)828 881 0.3% senior unsecured notes due 5/11/2027 (¥30.8 billion) (the “2027 Yen Notes”)(d)195 218 1.2% senior unsecured notes due 6